Published in Eur J Immunol on October 01, 1988
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80
Cellular and humoral antigenic epitopes in HIV and SIV. Immunology (1992) 1.38
Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J Virol (1993) 1.33
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1990) 1.28
Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology (2010) 1.21
Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J (1989) 1.08
Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect Immun (1996) 1.05
HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc Natl Acad Sci U S A (1990) 1.05
Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J Virol (1991) 1.00
Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides. J Exp Med (1990) 0.98
Predicting the size of the T-cell receptor and antibody combining region from consideration of efficient self-nonself discrimination. Proc Natl Acad Sci U S A (1993) 0.96
Common threads in persistent viral infections. J Virol (2009) 0.93
Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes. J Virol (1992) 0.84
Pentamers not found in the universal proteome can enhance antigen specific immune responses and adjuvant vaccines. PLoS One (2012) 0.83
Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities. Clin Exp Immunol (1994) 0.80
A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production. Immunology (1992) 0.79
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol (1981) 9.51
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell (1990) 9.37
Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc Natl Acad Sci U S A (1979) 7.24
A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 6.85
Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell (1986) 5.39
The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A (1993) 4.97
AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (1987) 4.96
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol (1989) 4.17
Optimal conditions for directly sequencing double-stranded PCR products with sequenase. Nucleic Acids Res (1990) 3.90
NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci (1992) 3.81
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes. Proc Natl Acad Sci U S A (1987) 3.80
Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature (1986) 3.73
Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol (1990) 3.72
Genomic exploration of the hemiascomycetous yeasts: 1. A set of yeast species for molecular evolution studies. FEBS Lett (2000) 3.71
Insertion of a rabbit beta-globin gene sequence into an E. coli plasmid. Nucleic Acids Res (1975) 3.66
T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today (1995) 3.60
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48
High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes. Antimicrob Agents Chemother (1979) 3.42
Isolation by molecular cloning of a fragment in the split ovalbumin gene. Nature (1978) 3.40
Molecular cloning of extensive sequences of the in vitro synthesized chicken ovalbumin structural gene. Nucleic Acids Res (1977) 3.32
Size estimate of the alpha beta TCR repertoire of naive mouse splenocytes. J Immunol (2000) 3.14
The characterization of the promoter of the gene encoding the p50 subunit of NF-kappa B indicates that it participates in its own regulation. EMBO J (1992) 2.86
Screening of cloned recombinant DNA in bacteria by in situ colony hybridization. Nucleic Acids Res (1978) 2.85
Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity (2000) 2.71
Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J (1987) 2.71
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65
Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature (1990) 2.61
Conjugative R plasmids in Streptococcus agalactiae (group B). Plasmid (1979) 2.57
Characterization of the genes coding for the Eco RV restriction and modification system of Escherichia coli. Nucleic Acids Res (1984) 2.52
Conjugative transfer of multiple-antibiotic resistance markers in beta-hemolytic group A, B, F, and G streptococci in the absence of extrachromosomal deoxyribonucleic acid. Plasmid (1981) 2.51
Methods for identification of recombinants of phage lambda. Proc Natl Acad Sci U S A (1976) 2.51
Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J (1991) 2.39
The ovalbumin gene region: common features in the organisation of three genes expressed in chicken oviduct under hormonal control. Nature (1979) 2.35
Cloning of several cDNA segments coding for human liver proteins. EMBO J (1983) 2.32
Cytotoxic T lymphocytes against HIV. AIDS (1990) 2.24
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21
Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature (1986) 2.21
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature (1991) 2.18
Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol (2001) 2.18
Inhibition of transcription factors belonging to the rel/NF-kappa B family by a transdominant negative mutant. EMBO J (1991) 2.15
Genomic exploration of the hemiascomycetous yeasts: 4. The genome of Saccharomyces cerevisiae revisited. FEBS Lett (2000) 2.14
Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med (1998) 2.13
Electron microscopy and restriction enzyme mapping reveal additional intervening sequences in the chicken ovalbumin split gene. Cell (1978) 2.08
Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. Genes Dev (1994) 2.08
Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires. Immunity (1998) 2.00
Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest (1999) 1.91
Structure of C-terminal half of two H-2 antigens from cloned mRNA. Nature (1981) 1.90
cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. Proc Natl Acad Sci U S A (1981) 1.90
Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol (1992) 1.89
Absence of significant H-2 and beta 2-microglobulin mRNA expression by mouse embryonal carcinoma cells. Nature (1982) 1.88
Multiple sequences related to classical histocompatibility antigens in the mouse genome. Nature (1981) 1.87
Most alpha/beta T cell receptor diversity is due to terminal deoxynucleotidyl transferase. J Exp Med (2001) 1.86
A cDNA clone containing the entire coding sequence of a mouse H-2Kd histocompatibility antigen. Nucleic Acids Res (1983) 1.86
Studies of the messenger RNA of bacteriophage lambda, I. Various species synthesized early after induction of the prophage. Proc Natl Acad Sci U S A (1968) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol (1997) 1.84
Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. Nucleic Acids Res (1982) 1.83
Structure and expression of the mouse beta 2-microglobulin gene isolated from somatic and non-expressing teratocarcinoma cells. EMBO J (1983) 1.82
Synthesis of an ovalbumin-like protein by Escherichia coli K12 harbouring a recombinant plasmid. Nature (1978) 1.82
DNA-DNA hybridization on filters at low temperature in the presence of formamide or urea. Biochimie (1971) 1.80
Lysogenization by bacteriophage lambda. III. Multiplicity dependent phenomena occuring upon infection by lambda. Biochimie (1974) 1.79
K-tuple frequency analysis: from intron/exon discrimination to T-cell epitope mapping. Methods Enzymol (1990) 1.79
The regulation and expression of MHC class I genes. Immunol Today (1990) 1.76
Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol (1992) 1.75
Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell (1987) 1.74
Lysogenization by bacteriophage lambda. I. Multiple infection and the lysogenic response. Mol Gen Genet (1973) 1.72
In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol (1991) 1.72
Genomic exploration of the hemiascomycetous yeasts: 18. Comparative analysis of chromosome maps and synteny with Saccharomyces cerevisiae. FEBS Lett (2000) 1.69
Public and private V beta T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J Exp Med (1994) 1.63
Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc Natl Acad Sci U S A (1992) 1.62
Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res (1993) 1.62
Implications of a Fab-like structure for the T-cell receptor. Immunol Today (1989) 1.61
Heuristic informational analysis of sequences. Nucleic Acids Res (1986) 1.60
Hybridization of filters with competitor DNA in the liquid phase in a standard and a micro-assay. Biochimie (1974) 1.60
Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol (1984) 1.58
Expression of class I genes in the major histocompatibility complex: identification of eight distinct mRNAs in DBA/2 mouse liver. Cell (1985) 1.57
Molecular cloning of the genome of poliovirus type 1. Proc Natl Acad Sci U S A (1981) 1.56
Working principles in the immune system implied by the "peptidic self" model. Proc Natl Acad Sci U S A (1987) 1.55
Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health (2010) 1.54
Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis. Int J Cancer (1973) 1.49
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A (1996) 1.47
In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. J Virol (2000) 1.45
Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Eur J Immunol (1975) 1.44
T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. Res Immunol (1995) 1.44
Nucleotide sequence and evolution of ETn elements. Proc Natl Acad Sci U S A (1987) 1.42
Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells. Nucleic Acids Res (1989) 1.41
Human immunodeficiency virus-related lymphocytic alveolitis. Chest (1988) 1.40
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40